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A necessary step in the genesis of an extracellular enveloped
virus particle is the formation of an outer virion membrane.
Often, virion membrane is derived from host cell membranes,
and this presents a problem because separation of virion from
host membrane is not a trivial or spontaneous step. Indeed,
viruses have evolved a number of strategies of varying
complexity to deal with this issue. Herpes- and poxviruses
for instance, have developed sequential membrane wrapping
and fusion activities that ultimately give rise to extracellular
virus particles with one or more lipid bilayers. For simpler
viruses that acquire their envelopes by budding through a
single host membrane bilayer, the fission of the nascent virion
membrane from that of the host cell requires a different
approach. At least some of these viruses have solved the
problem by mimicking and/or coopting factors that cells
usually employ during the formation of cytoplasm-containing
vesicles within endosomes. The virus and cell encoded
activities that are responsible for these virion and vesicle
budding events are currently an area of intense interest and a
number of interesting parallels and differences in the two
processes are being uncovered.0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.09.044
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The first compelling evidence that the simple enveloped
viruses might require specific virus or cell encoded activities in
order to separate virion from cell membrane came from studies
of HIV-1 mutants with curious assembly defects (Gottlinger et
al., 1991). Specifically, HIV-1 Gag proteins carrying mutations
in the carboxy-terminal p6 domain (Fig. 1A) were found to
assemble into relatively normal immature virions, but these
particles failed to separate from the host cell (Gottlinger et al.,
1991). This late-assembly defect was later recapitulated in
Rous sarcoma virus (RSV) wherein the defect mapped to the
p2b domain of Gag (Wills et al., 1994; Xiang et al., 1996).
Thereafter, numerous other retroviruses–essentially all that
were examined–were shown to encode similar activities. The
term late assembly or FL_-domain was coined to describe
motifs whose mutation induced the characteristic defective
assembly phenotype whereby virion and cell membranes failed
to separate. Examples of this phenotype for HIV-1 and murine
leukemia virus (MLV) are shown in Fig. 1B.
A theme that emerged from these studies was that retroviral
L-domains were one of three types, characterized by the
presence of distinct core sequence motifs (Fig. 1A). The
originally identified HIV-1 L-domain was encoded by a PTAP
motif (Gottlinger et al., 1991; Huang et al., 1995), while that of
RSV was shown to be a PPXY motif (Xiang et al., 1996).06) 55 – 63
www.e
Fig. 1. Viral Latc budding or FL_-domains. (A) Examples of L-domain motifs from diverse enveloped viruses are shown. Sometimes, a single recognizable motif is
present, but frequently, two L-domain motifs are present within a short linear sequence. (B) Characteristic late budding defect resulting from inhibition of L-domain
function in HIV-1 (top panels) or MLV bottom panels.
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encode L-domain activity (Bouamr et al., 2003; Wang et al.,
2002; Yasuda and Hunter, 1998; Yuan et al., 2000), while an L-
domain encoded by equine infectious anemia virus had the
sequence YPXL (Puffer et al., 1997). The identification of
sequence motifs in retroviruses led to the prediction that other
simple enveloped viruses that contained the same or similar
motifs within their structural proteins should also be dependent
on them for efficient budding. Indeed, this proved to be the
case, and today we know that PTAP and/or PPXY motifs
facilitate the budding of an array of retroviruses, filoviruses
(Harty et al., 2000), rhabdoviruses (Craven et al., 1999; Harty
et al., 1999) and arenaviruses (Perez et al., 2003) (Fig. 1A).
An important finding that emerged from early studies on L-
domains was their ability to function as relatively autonomous
units. In other words, they could promote virus release when
transplanted into a different context and when placed in
unnatural positions within a retroviral Gag protein (Parent et
al., 1995). While more recent studies have indicated that the
ability of L-domains to function in heterologous contexts is not
universal (Martin-Serrano et al., 2004; Strack et al., 2002), these
earlier findings proved extremely conceptually useful, in part
because they considerably facilitated the identification of new L-
domains. Indeed, the recent identification of a novel L-domain
motif FPIV in paramyxoviruses (Schmitt et al., 2005) is based, in
part, on the ability of the motif to functionally replace the PTAP
motif in HIV-1 Gag.Moreover, the autonomous way in which L-
domains appeared to function (Parent et al., 1995) suggested that
they would act by recruiting other viral or cellular factors rather
than directly affecting particle morphognenesis.
Class E vacuolar protein sorting factors are required for
L-domain activity
The notion that L-domains acted as docking sites for factors
proved correct and cellular proteins that are recruited by each
of the three prototype L-domains have been identified. PTAP
motifs, for example, act by recruiting Tsg101 (Demirov et al.,
2002; Garrus et al., 2001; Martin-Serrano et al., 2001; VerPlank
et al., 2001). A variety of physiological activities had
previously been ascribed to this protein, but its primary roleis widely accepted to be in the determining the fate of
transmembrane proteins at the limiting membranes of endo-
somes (see below). Evidence that Tsg101 recruitment is the
mechanism by which PTAP L-domains facilitate virus budding
is compelling: (1) there is an almost perfect correlation between
the ability of HIV-1 p6 mutants to bind Tsg101 and to mediate
virion production (Garrus et al., 2001; Martin-Serrano et al.,
2001); (2) depletion of Tsg101 using small interfering RNA
induces a characteristic L-domain mutant-like budding defect
that is reversed by reintroduction of Tsg101 (Garrus et al.,
2001); (3) artificially tethering Tsg101 to sites of HIV-1 particle
assembly Gag reverses the late budding defect induced by
PTAP mutation (Martin-Serrano et al., 2001); (4) expression of
PTAP binding fragments of Tsg101 induces a late budding
defect in HIV-1 (Demirov et al., 2002); (5) expression of either
HIV-1 Gag or Ebola virus matrix protein in cells induces the
recruitment of Tsg101 from intracellular locations to particle
assembly sites at the plasma membrane (Martin-Serrano et al.,
2001). Tsg101 contains several protein domains that are
required for virus release. An N terminal ubiquitin E2 variant
(UEV) domain binds PTAP motifs (Garrus et al., 2001;
VerPlank et al., 2001) and structural analysis reveals the
presence of a pocket in which PTAP binds that may be a viable
target for pharmacologic intervention (Pornillos et al., 2002a,
2002b). A proline rich domain of unknown function links the
UEV domain to coiled-coil and C-terminal domains that
mediate interactions with other protein partners (Bache et al.,
2004; Bishop and Woodman, 2001; Eastman et al., 2004;
Martin-Serrano et al., 2003b; Stuchell et al., 2004), and induces
Tsg101 multimerization (Martin-Serrano et al., 2003b).
Tsg101 is a member of a family of proteins whose orthologs
in yeast were identified in screens for factors that are required
for the sorting of proteins to the interior of the vacuole/
lysosome (see Katzmann et al., 2002 and Pornillos et al.,
2002a, b for review). In yeast, the Tsg101 ortholog is termed
Vps23 and in addition to sorting defects, genetic ablation of
this, or any one of approximately 18 or so other factors, results
in the formation of a so-called Fclass E_ compartment
(Katzmann et al., 2002). This is an aberrant enlarged endosome
that is thought to arise because of a failure in inward
invagination and budding of late endosomal membranes to
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was required for the release of certain enveloped viruses was
especially intriguing because of obvious similarities between
the process of viral budding and MVB vesicle budding
(Pornillos et al., 2002a, 2002b). Indeed, the two processes
can be viewed as fundamentally the same, in that both involve
membrane invagination away from the cytoplasm and the
pinching off of a vesicle, whose contents are cytoplasmic in
origin, into a lumenal or extracellular milieu. Viral budding and
vesicle budding differ only in that they occur at different sites
in the cell, and the major contents of the resulting membrane
enclosed unit are viral in one case and cellular in the other.
Thus, it was intuitively satisfying that viral budding would
exploit cellular factors normally required for vesicle budding
and subsequent investigations have expanded on this notion. In
yeast, a major subset of the class E factors participate in the
formation of at least three major protein complexes, termed
Fendosomal sorting complexes required for transport’ (ESCRT)
-I, -II and -III (Babst et al., 2002a, 2002b; Katzmann et al.,
2001) (see Fig. 2). The anatomy of these complexes is largely
preserved in mammals and most of the mammalian compo-
nents of the class E VPS machinery could be identified by
sequence homology to their yeast counterparts (Pornillos et al.,
2002a, 2002b). Perhaps unsurprisingly, however, the mamma-
lian class E VPS machinery has been slightly elaborated during
eukaryotic evolution. Tsg101 is one subunit of mammalian
ESCRT-I, which, in addition, includes two additional proteins
VPS28 and VPS37. While the VPS28 binding property of
Tsg101 could be shown to be required in order for it to mediate
HIV-1 release (Martin-Serrano et al., 2003b; Stuchell et al.,
2004), the identity of human VPS37 was not immediately
obvious, given that no closely related homologue could be
easily identified in human sequence databases. However, fourFig. 2. Protein:protein interactions among components of the mammalian class E VPS
are shown in yellow, green and red, respectively. There are minor differences in the p
proteins and more extensive differences in the yeast counterpart (see text for detaildifferent versions of VPS37 were recently identified by
homology searching, and by using yeast two-hybrid screening
with Tsg101 as a bait (Bache et al., 2004; Eastman et al., 2004;
Stuchell et al., 2004). Two of these have been shown to be
important for PTAP-dependent viral budding (Eastman et al.,
2004). Thus, it appears that a complete ESCRT-I complex is
recruited by PTAP motifs and required to induce virus release.
Two other protein complexes form important subcompo-
nents of the mammalian class E VPS machinery. One complex,
termed ESCRT-II comprises 3 proteins, EAP20, EAP30 and
EAP45. A third complex is composed of so-called Fcharged
MVB proteins_ (CHMPs). There are 6 CHMP-related proteins
in yeast, some of which have been duplicated in mammals to
make a total of 10 proteins. Several studies have documented
protein:protein interactions between ESCRT-complex compo-
nents and directed yeast two-hybrid screens have revealed
rather extensive protein:protein interaction networks encom-
passing the ESCRT complex components and other class E
VPS factors (Babst et al., 2002a, 2002b; Bowers et al., 2004;
Martin-Serrano et al., 2003a, 2003b; Strack et al., 2003; von
Schwedler et al., 2003) (Fig. 2). While there are some
differences in details of these studies (particularly there are
differences between yeast and mammalian systems), there is
general concordance in descriptions of the mammalian class E
VPS pathway (Martin-Serrano et al., 2003a; von Schwedler et
al., 2003).
In addition to forming a complex with VPS28 and VPS37,
Tsg101 also binds to two other mammalian class E VPS
factors, AIP-1/ALIX and Hrs, orthologues of the yeast class E
VPS factors, Bro1 and Vps27, respectively (Bache et al., 2003;
Katzmann et al., 2003; Lu et al., 2003; Martin-Serrano et al.,
2003a; Pornillos et al., 2003; Strack et al., 2003; von
Schwedler et al., 2003). Like various viral structural proteins,pathway. Factors contributing to the complexes known as ESCRT-I, -II and -III
recise nature of the interaction network in the literature pertaining to mammalian
s) but the overall anatomy of the network is largely agreed upon.
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to bind to Tsg101 (Bache et al., 2003; Lu et al., 2003; Pornillos
et al., 2003). In addition, there are PT/SAP independent
interactions involving the C-terminal domain of Tsg101 and
each of the four variants of VPS37 also binds Hrs (Bache et al.,
2004; Eastman et al., 2004; Stuchell et al., 2004). Overall, there
appears to be a particularly intimate association between Hrs
and ESCRT-I. Because of this, and the fact that Hrs binds to
phosphatidyl inositol-3-phosphate on endosomal membranes,
Hrs may be the major factor that nucleates the recruitment of
the class E VPS pathway to form a budding vesicle (Katzmann
et al., 2002; Pornillos et al., 2002a, 2002b; Raiborg et al.,
2003). While Hrs itself appears not to be required for viral
budding (S. Eastman personal communication), an Hrs
fragment can substitute for HIV-1 L-domain and mediate
particle release when fused to the carboxy-terminus of HIV-1
Gag (Pornillos et al., 2003), presumably because of its ability
to efficiently recruit ESCRT-I.
Another ESCRT-I binding protein, AIP-1/ALIX, plays a
particularly important role in viral budding not only because it
appears to act as one bridging factor between ESCRT-I and
ESCRT-III, but also because it is bound directly by a second
class of L-domains (Martin-Serrano et al., 2003a, 2003b; Strack
et al., 2003; von Schwedler et al., 2003). Indeed, the
incorporation of significant quantities of AIP-1/ALIX into
primate lentivirus particles led to the discovery that they encode
a second L-domain that conforms to the consensus LXXLF
within p6, in addition to PT/SAP motif (Strack et al., 2003). In
fact, the LXXLF motif carried by primate lentitiviruses and
YPXL motifs carried by the equine lentivirus EIAVappear to be
variants of the same class of L-domain, since both bind AIP-1/
ALIX and both are dependent on it for activity (Martin-Serrano
et al., 2003a, 2003b; Strack et al., 2003; von Schwedler et al.,
2003).
The role of ESCRT-II in viral budding is less clear. Each of the
ESCRT-II components EAP45, EAP30 and EAP20 binds to each
other and to the ESCRT-III protein CHMP6 (Martin-Serrano et
al., 2003a, 2003b; von Schwedler et al., 2003). Moreover, one of
two studies that tested for interactions between ESCRT-I and
ESCRT-II found that ESCRT-II proteins bound to Tsg101 (von
Schwedler et al., 2003).While a structure has been solved for the
ESCRT-II complex from yeast (Hierro et al., 2004; Teo et al.,
2004), and ESCRT-II can bind to ubiquitin (Alam et al., 2004),
whether and how this complex plays an essential role in vesicle
and viral budding is unknown at present.
There is strong evidence that ESCRT-III plays an important
role in viral budding, but the precise details of how this occurs
are not well understood. The CHMP proteins that comprise
ESCRT-III exhibit a significant degree of sequence homology
to each other, and to corresponding yeast proteins, and show a
substantial predicted propensity to form coiled-coils. More-
over, they exhibit a striking distribution of charged amino acid
residues, with large clusters of basic and acidic amino acid
residues situated toward their amino and carboxy termini,
respectively (Howard et al., 2001). In addition, at least some
CHMP proteins have affinity for membranes (Babst et al.,
2002a), with CHMP6 carrying an amino-terminal myristoylgroup. CHMP proteins also have extensive interactions with
each other and with other class E VPS factors (Babst et al.,
2002a; Martin-Serrano et al., 2003a, 2003b; Strack et al., 2003;
von Schwedler et al., 2003). Specifically, CHMP6 binds to all
ESCRT-II components, each CHMP4 isoform (A, B, and C)
binds to AIP-1/ALIX, and CHMP5 binds to LIP5 (Ward et al.,
2005). The remaining CHMP proteins CHMP1 (A and B),
CHMP2 (A and B) and CHMP3 all bind to an ATPase VPS4
which plays an especially important role on the class E VPS
pathway (see below). VPS4 may bind to additional, perhaps all,
CHMP proteins although there is some disagreement in the
literature on this point (Martin-Serrano et al., 2003a; von
Schwedler et al., 2003). In general, while there are some
differences among various studies in the details of precisely
which CHMP proteins bind to each other and to VPS4, the
anatomy of ESCRT-III appears to be largely conserved in yeast
and humans (Babst et al., 2002a; Bowers et al., 2004; Martin-
Serrano et al., 2003a, 2003b; von Schwedler et al., 2003).
There are a few reasons to think that CHMP proteins and
VPS4 comprise the core machinery that mediates the membrane
remodeling and/or fission events that separates nascent virions
or vesicles from their parent membranes. First, catalytically
inactive VPS4 mutants have a dominant negative (DN)
phenotype and their expression induces the formation of class
E compartment-like aberrant endosomes in both yeast and
mammalian cells (Babst et al., 1998; Bishop and Woodman,
2000) on which most all of the known components of the class E
VPS machinery accumulate. Importantly, this manipulation
inhibits retroviral budding in a general way, i.e. irrespective of
which particular type of L-domain is carried by the respective
virus (Bishop and Woodman, 2000; Martin-Serrano et al.,
2003b; Tanzi et al., 2003). This pan-specific ability to inhibit
retrovirus budding is shared by dominant negative versions of
CHMP proteins that can be created by fusion of a bulky or
multimerizing protein at amino or carboxy termini of certain
CHMP proteins (Martin-Serrano et al., 2003a, 2003b; Strack et
al., 2003; von Schwedler et al., 2003). In contrast, it is possible to
create rather specific inhibitors of PTAP, PPXYor YPDL type L-
domains by expressing truncated forms of their respective
cofactors (Demirov et al., 2002; Martin-Serrano et al., 2003a,
2003b). In addition, siRNA-mediated depletion of Tsg101
inhibits PTAP type L-domain activity, but has only minimal
effects on YPDL or PPXY L-domains (Garrus et al., 2001;
Martin-Serrano et al., 2003b; Tanzi et al., 2003) while AIP-1/
ALIX depletion profoundly attenuates YPDL L-domain func-
tion but barely affects PTAP and PPXY L-domains (Martin-
Serrano et al., 2003a). Overall, these types of experiments
suggest that certain components are exploited in an L-domain-
specific manner to access the class E VPS machinery, while
others, specifically CHMP proteins and VPS4, appear to play a
more general and central role in enveloped virus release.
HECT ubiquitin ligases are required for PPXY-type
L-domain activity
PTAP- and YPDL-type L-domains bind directly to class E
VPS factors, but although PPXY L-domains are clearly
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inhibition by VPS4 and CHMP protein-based dominant
inhibitors) (Garrus et al., 2001; Martin-Serrano et al., 2003a,
2003b), they apparently access it in a different way. PPXY is a
consensus sequence for interaction with WW domains, a
protein module that is present in multiple copies in HECT
(Homologous to E6AP C-terminus) ubiquitin ligases. While
yeast has a single HECT ubiquitin ligase (Rsp5) (Huibregtse et
al., 1995), humans encode at least nine (Rotin et al., 2000). The
most widely studied member of this family of proteins, Nedd4,
is recruited by PPXY motifs in, for example, the cytoplasmic
domains of the amiloride-sensitive epithelial Na+ channel
(ENaC) and induces its down regulation (Staub et al., 1996,
2000). In addition to central WW domains, this group of
proteins also encodes an amino-terminal C2 domain that directs
membrane binding and localization and a carboxy-terminal
HECT ubiquitin ligase catalytic domain, that can modify
substrates by the addition of ubiquitin (Dunn and Hicke, 2001;
Hicke, 2001).
Several studies have suggested that this family ubiquitin
ligases might play a role in viral budding. For example,
overexpression of various HECT ubiquitin ligase-derived WW
domains can inhibit viral budding. In addition, the PPXY
motifs present in the structural proteins of vesicular stomatitis
virus (VSV) (Harty et al., 1999), Ebola virus (Harty et al.,
2000; Yasuda et al., 2003), Rous sarcoma virus (RSV)
(Kikonyogo et al., 2001), human T-cell leukemia virus (Blot
et al., 2004; Bouamr et al., 2003; Heidecker et al., 2004;
Sakurai et al., 2004) and Mason Pfizer monkey virus (Yasuda
et al., 2002) have been reported bind to various HECT
ubiquitin ligases including Nedd4, LDI-1, 2, BUL1, WWP1,
WWP2 and Itch. In addition, an ENaC-derived PPXY-contain-
ing peptide sequence that is capable of binding multiple HECT
ubiqutin ligases exhibits L-domain activity in the context of
retroviral Gag proteins (Strack et al., 2000, 2002). Finally,
overexpression of certain HECT ubiqutin ligases can modestly
increase virus budding in some cases (Sakurai et al., 2004;
Yasuda et al., 2002, 2003) and our own studies show that
WWP1, WWP2 or Itch overexpression rescues a specific
release defect that has been induced by overexpression of a
WW domain protein fragment or by PPXY motif mutation
(Martin-Serrano et al., 2005). Importantly, rescue of specific
release defects required that the rescuing HECT ubiquitin
ligase be catalytically active (Martin-Serrano et al., 2005).
Several HECT ubiquitin ligases are ubiquitously expressed
(Wood et al., 1998) and could play redundant roles in PPXY-
dependent viral budding. However, of the other HECT
ubiquitin ligases tested, all bind to a more limited subset of
viral PPXY motifs than do WWP1, WWP2 and Itch (Martin-
Serrano et al., 2005). In addition, WWP1, WWP2 and Itch are
unique among HECT ubiquitin ligases in that they can be
convincingly demonstrated to be recruited to sites of viral
budding by MLV Gag or Ebola virus matrix proteins, and
fragments of them can be demonstrated to specifically induce a
late budding defect in MLV (Martin-Serrano et al., 2005).
Nonetheless, precisely which HECT ubiquitin ligase is used
during viral budding probably depends on expression levels ininfected tissues, perhaps on its subcellular localization, and the
particular sequence context of the viral PPXY motif.
How do ubiquitin and ubiquitin ligases mediate viral
budding?
While recent studies demonstrate that the HECT active site,
and presumably therefore, ubiquitination of some substrate
protein, is required for PPXY-dependent viral budding, the
functional target of ubiquitination during viral budding remains
unclear. The most obvious candidates are the viral structural
proteins themselves and several studies indicate that PPXY
motifs induce ubiquitination of retroviral Gag proteins (Blot et
al., 2004; Martin-Serrano et al., 2004; Ott et al., 2000; Strack et
al., 2000). In addition, there is one example where mutation of
multiple ubiquitin acceptor sites in RSV Gag has been shown
to inhibit virus release (Spidel et al., 2004). In principle,
deposition of ubiquitin, be it on virion or bystander proteins,
may stabilize recruitment class E VPS factors, several of which
bind ubiquitin (Alam et al., 2004; Bishop et al., 2002; Garrus
et al., 2001; Polo et al., 2002), at sites of viral budding.
Alternatively, cellular factors, including the class E VPS factor
Hrs, may also be ubiquitinated by HECT ubiquitin ligases
(Marchese et al., 2003; Polo et al., 2002). There is clear
evidence that Rsp5-dependent trafficking in yeast can require
ubiquitination of substrates other than the cargo protein (Dunn
and Hicke, 2001). In principle, therefore, ubiquitination of
factors other than viral proteins could influence their ability to
promote viral budding.
While HECT ubiquitin ligases were thought to influence the
fate of transmembrane proteins primarily because of their
ability to modify transmembrane protein substrates or essential
trans-acting factors, two lines of evidence suggest that HECT
domains have additional functions. First, overexpressed
WWP1 fragments that lack a HECT domain are markedly
more potent inhibitors of PPXY-dependent viral budding than
are those carrying catalytically inactive HECT domains
(Martin-Serrano et al., 2005). This suggests that catalytically
inactive HECT domains may retain some residual function.
Second, the isolated HECT domain of WWP1, which does not
ordinarily bind to membrane, appears to be a sufficient signal
for recruitment to class E-like compartments induced by a
expression of a catalytically inactive VPS4 mutant in mam-
malian cells (Martin-Serrano et al., 2005). While there are no
known interactions between HECT domains and class E VPS
factors, this finding suggests that some interaction between
HECT domains and some component of the class E pathway
exists, most likely involving an unidentified bridging factor.
A remaining question is whether ubiquitination in any
form is required for release of viruses that encode PTAP or
YPXL/LXXLF-type L-domains. Recent evidence suggests
that the ability of viral L-domains to promote HIV-1 particle
release correlates with their ability to reduce rather than
increase the small amount of ubiquitin carried by the HIV-1
Gag protein (Gottwein and Krausslich, 2005; Martin-Serrano
et al., 2004). Although mammalian class E VPS factors have
not yet been unequivocally demonstrated to recruit deubiqui-
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2000) and one mammalian class E VPS factor, namely HPB/
STAM, has been reported to bind to the deubiquitinating
enzyme, UBPY (Kato et al., 2000). Thus, correlating the
extent of viral protein ubiquitination with the efficiency of
virus release is difficult and likely confounded by several
variables in particular the potentially numerous ubiquitin
ligases and deubiquitinating enzymes that may be associated
with the various components of the mammalian class E VPS
machinery.
Concluding perspectives and remaining questions
While recent years have seen rather dramatic advances in
understanding of how enveloped viruses achieve separation
from the cell that gave rise to them, several pressing questions
remain. A central question is in the precise role of ubiquitin
modification in virus release. This remains enigmatic, and
while the above discussion communicates several plausible
hypotheses, none has unequivocal experimental support.
Treatment of cells with proteasome inhibitors can induce an
L-domain mutant-like budding defect (Ott et al., 2003; Patnaik
et al., 2000; Schubert et al., 2000) and it is presumed, but not
clearly demonstrated, that this is due to depletion of free
ubiquitin (Patnaik et al., 2000). Proteasome inhibition could
have rather pleiotropic effects, perhaps including generalized
inhibition of the class E VPS pathway. A vexing issue is that
several of the candidate ubiquitin-binding or ubiquitin-modi-
fied proteins among the class E VPS factors appear not to be
required in a general manner for viral budding (Alam et al.,
2004; Bishop et al., 2002; Garrus et al., 2001; Polo et al., 2002).
This may be due to redundancy, but nonetheless, this makes a
demonstration of a functional role somewhat difficult. An
additional potential problem in assigning specific roles to
particular factors and L-domains in virus release is the
possibility (or probability) that there remain more of each to
be discovered. The known class E VPS proteins were largely
discovered based on their ability to induce sorting defects in
yeast when mutated (Katzmann et al., 2002; Raiborg et al.,
2003) but this, by definition, required that the yeast remained
viable. There may very well be additional complexity in the
mammalian machinery and perhaps additional undiscovered
factors are crucial for viral budding. Similarly, surveys of viral
structural proteins for viral L-domain motifs are far from
exhaustive. Most work on various L-domain motifs depends on
a few seminal descriptions of PTAP, PPXYand YPDL motifs in
retroviruses. The recent discovery of a completely novel L-
domain in paramyxoviruses (Schmitt et al., 2005) illustrates
that the L-domain Fdatabase_ is unlikely to be complete. Indeed,
the recent appreciation that L-domains can exhibit quite strong
context dependence (Martin-Serrano et al., 2004; Strack et al.,
2002), could be explained by the presence of undiscovered
underlying L-domains that act in a combinatorial manner to
stimulate factor recruitment and virus release.
At present, we also do not have a clear idea as to what role
each class E VPS protein plays in virus release and whether
requirement for various activities differs among differentviruses. The various morphologies of budding structures that
are induced during virion formation might impose differing
requirements for L-domain-recruited factors. In their cellular
context, it appears that class E VPS factors should mediate at
least three distinct activities, namely (i) the sorting of cargo
proteins, (ii) membrane invagination to form a budding
vesicular structure and (iii) membrane fission to form an intact
vesicle. Different viruses might depend on these activities to
differing extents, as such require recruitment of partial or
complete subsets of class E VPS factors. Consistent with this
idea, mutation of the PPXY motifs found in MPMVor HTLV-I
a defect in which budding is arrested at an earlier stage than is
typical of other retroviruses harboring mutant L-domains
(Gottwein et al., 2003; Le Blanc et al., 2002). In addition,
inhibition of MLV L-domain function can lead to the
formation of tubes rather than the virtually complete spherical
virions that characterize other retroviral L-domain mutants
(Martin-Serrano et al., 2003a; Yuan et al., 2000) (Fig. 1B).
Thus, L-domains could indeed recruit factors that play an
important role in virion morphogenesis, dependent on the
contribution of the viral structural proteins to defining particle
morphology.
Nonetheless, it does seem that the minimal contribution that
class E VPS factor recruitment makes is to induce fission of
virion and cellular membranes. At present, it is unknown what
constitutes the minimal components of the class E VPS
pathway required for this step, but it seems most likely that
the CHMP proteins and VPS4 are responsible, given their
general requirement in viral budding. Activities such as the
membrane curving activity ascribed to AIP-1/ALIX (Matsuo et
al., 2004) do not appear to be required in a general sense for
viral budding, because depletion of this protein using siRNA-
based approaches does not have major impact on virus release
that is mediated by PTAP or PPXY motifs (Martin-Serrano et
al., 2003a). Among the CHMP proteins, work has centered
around dominant negative fusion proteins and, surprisingly,
even some CHMP proteins appear dispensable for the release
of HIV-1 (Ward et al., 2005). Given this uncertainty in the
minimal protein machinery required for the induction of
membrane fission, even a rudimentary understanding of the
mechanics by which enveloped virus release occurs appears
some way off.
Finally, an important practical question is whether the class
E VPS machinery can be manipulated in order to attenuate viral
replication for therapeutic benefit. At first glance, this seems
unlikely, given the crucial role that the sorting of membrane
proteins at the limiting membrane of endosomes plays in the
life of cells, and the fact that the known L-domains appear to
act by mimicking recruitment events that are normally
mediated by cellular proteins. Nonetheless, it may be possible
for limited inhibition of L-domain:class E VPS factor interac-
tions to have some therapeutic role in the context of a life
threatening acute viral infection. Given the small size of the
know viral L-domains, and the fact that the PTAP motif, for
example, binds within a pocket in Tsg101 (Pornillos et al.,
2002a, 2002b), such an approach to developing broad spectrum
antiviral appears possible.
P.D. Bieniasz / Virology 344 (2006) 55–63 61Even if there is no immediate therapeutic benefit to be
derived from recent discoveries of the mechanism by which
enveloped virus bud from cells, it is clear that the unanticipated
complexities in the way that host cells and viral proteins
interact during viral budding have informed the fields of
virology and cell biology in ways that are only beginning to be
appreciated.
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